Main Unit of the company’s business, Eurofarma ranks today a prominent position, being the 2nd most prescribed laboratory by the medical community. It represents 44.6% of the company’s revenues and annually markets more than 59 million units of medicine. This expressive result is the fruit of more than 1,700 employees in its sales force work, the largest of Brazil in the pharmaceutical segment.
The strategy is based on the capillarity of the promotion, with the country’s largest sales force, to the broad portfolio and to the service to all medical specialties.
With several releases throughout the year, the area has in its portfolio highlights as the contraceptive Tâmisa®, the anti-acne Selena® and anti-depressive Pondera®.